Vaccine Approval US FDA "Science is Judgment Criteria" Practical Use Rapid Movement Suppression September 24, 10:39
The head of the US FDA (Food and Drug Administration) testified in the Senate over the development of a new coronavirus vaccine, emphasizing that vaccine approval will be carefully based on scientific judgment, and restraining the rush to put it into practical use. Did.
FDA Director Hahn, who testified at a hearing in the U.S. Senate on the 23rd, said that approval and approval of the new coronavirus vaccine will be shown to be safe and effective through a third-stage clinical trial, which is the final stage of development. He showed the recognition that it is indispensable.
"All vaccines are not licensed or approved unless they meet the strict FDA standards. Science cannot change it to any pressure based on judgment," Hahn emphasized.
At the same hearing, CDC Director of the Centers for Disease Control and Prevention Redfield said, "We will have 700 million vaccines ready at the end of March or April next year."
Regarding the vaccine for the new coronavirus, President Trump has repeatedly stated that it will be available in October.
In response to these statements, outside experts have expressed concern that the administration may be pressured to rush the permit ahead of the November presidential election, but Hahn and his colleagues testified. It is perceived as denying these concerns and restraining the rush to put it into practical use.